Key Highlights
- Q1 adjusted earnings per share reached 55 cents for DuPont, surpassing analyst projections of 48 cents
- Revenue totaled $1.68 billion for the quarter, marginally exceeding the $1.67 billion forecast
- Annual EPS projections elevated to $2.35–$2.40 range, compared with previous $2.25–$2.30 outlook
- Management initiated a $275 million accelerated share buyback program with immediate effect
- Pricing adjustments of approximately 1% implemented to counter elevated input expenses linked to Iran tensions
Shares of DuPont (DD) advanced 1.6% to reach $46.15 during premarket hours on Tuesday following the materials and chemicals manufacturer’s first-quarter performance that topped analyst projections and prompted management to elevate annual forecasts.
The company delivered adjusted earnings of 55 cents per share, comfortably exceeding the 48-cent consensus compiled by FactSet. Revenue climbed to $1.68 billion from $1.61 billion in the corresponding period last year, narrowly surpassing the $1.67 billion analyst estimate.
On a GAAP basis, DuPont reported profitability of $161 million, translating to 39 cents per share, representing a sharp reversal from the $589 million loss, or $1.40 per share, recorded in the year-ago quarter.
Year-over-year comparisons require context given corporate restructuring. The company completed the separation of its electronics division, Qnity Electronics, creating differences in comparable figures across periods.
The first-quarter performance includes a three-cent-per-share benefit from discontinued operations connected to the sale of the Aramids business, which reached completion on April 1.
Annual Projections Move Higher
Management elevated full-year adjusted earnings expectations to a range of $2.35 to $2.40 per share, an increase from the previously communicated $2.25 to $2.30 target. Revenue guidance also received an upward adjustment to $7.16–$7.22 billion from the earlier $7.08–$7.14 billion range.
These revised projections position the company above current Street expectations, which stand at $2.27 per share and $7.10 billion in revenue.
Second-quarter guidance calls for adjusted earnings of approximately 59 cents per share on revenue near $1.8 billion. Analyst consensus had anticipated 58 cents on $1.8 billion in sales, placing the outlook closely aligned with expectations.
Chief Executive Lori Koch highlighted organic expansion, margin improvement, and double-digit adjusted earnings growth as standout achievements from the quarter. Chief Financial Officer Antonella Franzen explained that updated annual projections incorporate approximately 4% organic growth, with roughly 1% attributable to pricing actions designed to offset elevated input expenses stemming from tensions involving Iran.
Capital Return Initiative and Operational Results
The company unveiled a $275 million accelerated share repurchase program launching without delay. This initiative represents a portion of the broader $2 billion buyback authorization the board granted in November, which featured a $500 million accelerated component.
Looking at operational segments, Healthcare & Water Technologies generated 6% year-over-year revenue growth, while profit margins expanded by 1.1 percentage points. The Diversified Industrials segment delivered 3% sales advancement, accompanied by an identical 1.1 percentage point margin enhancement.
DD shares had declined approximately 9% following the commencement of hostilities involving Iran on February 28, as market participants assessed potential impacts from higher oil prices on production costs. Entering Tuesday’s session, the stock maintained a 13% gain year-to-date and had appreciated 66% over the trailing twelve months.
The second-quarter outlook calling for 59 cents in adjusted earnings per share on $1.8 billion in revenue represents the company’s latest forward guidance.
